Trade Evotec AG - EVT CFD
Add to favourite- Summary
- Historical Data
Spread | 0.035 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.01796% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.004262% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Germany | ||||||||
Commission on trade | 0% |
Prev. Close | 5.905 |
Open | 5.77 |
1-Year Change | -58.87% |
Day's Range | 5.76 - 6.045 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 2, 2025 | 5.905 | -0.080 | -1.34% | 5.985 | 5.985 | 5.725 |
Apr 1, 2025 | 6.120 | 0.050 | 0.82% | 6.070 | 6.185 | 5.990 |
Mar 31, 2025 | 6.040 | 0.135 | 2.29% | 5.905 | 6.070 | 5.740 |
Mar 28, 2025 | 6.000 | -0.015 | -0.25% | 6.015 | 6.040 | 5.895 |
Mar 27, 2025 | 6.075 | -0.095 | -1.54% | 6.170 | 6.200 | 5.970 |
Mar 26, 2025 | 6.290 | -0.130 | -2.02% | 6.420 | 6.480 | 6.265 |
Mar 25, 2025 | 6.415 | -0.195 | -2.95% | 6.610 | 6.665 | 6.365 |
Mar 24, 2025 | 6.585 | 0.220 | 3.46% | 6.365 | 6.665 | 6.330 |
Mar 21, 2025 | 6.320 | -0.070 | -1.10% | 6.390 | 6.435 | 6.150 |
Mar 20, 2025 | 6.415 | -0.085 | -1.31% | 6.500 | 6.605 | 6.300 |
Mar 19, 2025 | 6.505 | -0.090 | -1.36% | 6.595 | 6.635 | 6.405 |
Mar 18, 2025 | 6.600 | 0.070 | 1.07% | 6.530 | 6.745 | 6.495 |
Mar 17, 2025 | 6.430 | 0.145 | 2.31% | 6.285 | 6.495 | 6.275 |
Mar 14, 2025 | 6.300 | 0.100 | 1.61% | 6.200 | 6.385 | 6.125 |
Mar 13, 2025 | 6.230 | 0.110 | 1.80% | 6.120 | 6.250 | 6.020 |
Mar 12, 2025 | 6.160 | -0.070 | -1.12% | 6.230 | 6.270 | 6.065 |
Mar 11, 2025 | 6.185 | -0.195 | -3.06% | 6.380 | 6.500 | 6.125 |
Mar 10, 2025 | 6.355 | -0.235 | -3.57% | 6.590 | 6.710 | 6.275 |
Mar 7, 2025 | 6.620 | -0.090 | -1.34% | 6.710 | 6.955 | 6.540 |
Mar 6, 2025 | 6.755 | -0.415 | -5.79% | 7.170 | 7.250 | 6.715 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Evotec Company profile
About Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Evotec SE revenues increased 20% to EUR431M. Net income increased from EUR5.8M to EUR247M. Revenues reflect EVT Execute segment increase of 22% to EUR329M, EVT Innovate segment increase of 36% to EUR101.9M, United States segment increase of 32% to EUR142.9M, Others segment increase of 30% to EUR47.5M, United Kingdom segment increase of 8% to EUR47.2M.
Industry: | Biotechnology & Medical Research (NEC) |
Essener Bogen 7
HAMBURG
HAMBURG 22419
DE
News

Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com